Stock #3 Quarterly Update Q4FY25 – Hindi

Our recommended healthcare stock reported its strongest quarterly performance yet, with revenue growing 15% year-on-year and EBITDA margins reaching over 26%. While profit after tax remained largely stable, operational efficiency and consistent performance across key units supported overall growth. With a continued focus on expanding domestic operations and optimizing capacity, the business appears to be steadily executing its long-term strategy. However, with expectations rising, the real test lies in sustaining this momentum. Watch as we break down the quarterly numbers, explore the operational trends, and assess what lies ahead in this healthcare story.